Management of Invasive Bladder Neoplasms-Reference-Cited by-同舟云学术

Management of Invasive Bladder Neoplasms

Published:1989 Issue: Volume: Page:95-118
ISSN:0177-8994
Container-title:Combination Therapy in Urological Malignancy
language:
Short-container-title:

Author:

Sternberg Cora N.,Scher H. I.

Publisher

Springer London

Link

http://link.springer.com/content/pdf/10.1007/978-1-4471-1655-4_6.pdf

Reference109 articles.

1. Al-Sarraf M, Frank J, Smith JA et al. (1984) Phase H trial of cyclosphosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: A Southwest Oncology Group Study. Cancer Treat Rep 69: 189

2. Bander NH (1987) Monoclonal antibodies in urologic oncology. Cancer 60 [Suppl 4a]: 514–520

3. Batata MA, Chu FCH, Hilaris BS et al. (1981) Factors of prognostic and therapeutic significance in patients with bladder cancer. Int J Radiat Oncol Biol Phys 7: 575–579

4. Bell DR, Gerlach JH, Kartner N et al. (1986) Detection of p-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J Clin Oncol 3: 311–315

5. Biedler JL, Meyers MB, Spengler BA (1988) Cellular concomitants of multidrug resistance. In: Mechanisms of Drug Resistance in Neoplastic Cells. Bristol—Myers Symposium. Academic Press, New York

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen;Oncology;2005

2. Pharmakologische Therapie des lokal fortgeschrittenen und metastasierten Harnblasenkarzinoms;Pharmakotherapie in der Urologie;2002

3. Chemotherapy and management of bladder tumours;BJU International;2001-12-24

4. Infiltrating Bladder Cancer: Surgery and Chemotherapy;Urologia Journal;1998-08

5. NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN ADVANCED DISEASE?WHAT ARE THE EFFECTS ON SURVIVAL AND PROGNOSIS?;International Journal of Urology;1995-06